Recent research suggests that protective antibodies from Covid-19 vaccines, specifically the mRNA type, tend to decline ...

A study suggests that catching COVID-19 significantly raises the risk of developing ME/CFS (formerly called "chronic fatigue ...

Shares in Sorrento Therapeutics rose 158% on Friday after it revealed plans to start human trials of an antibody therapy that achieved complete inhibition of the coronavirus in preclinical studies.

Further, the company estimates that every clinical variant reported in the CDC COVID Tracker since the Omicron BA.1 lineage has been susceptible to pemivibart, even if untested, due to the ...

Hopes that coronavirus antibody tests could help the UK end its lockdown have been dealt a blow - after the World Health Organization questioned whether they offer any guarantee of immunity.

Here the authors analyze data from COVAIL trial participants receiving an mRNA second COVID-19 vaccine boost and show that, while neutralizing antibody titer is correlated with Omicron COVID-19 ...

You're watching Coronavirus in Context. I'm Dr. John Whyte, chief medical officer at WebMD. What's the role of antibodies against coronavirus infection? It's one of the biggest questions that we ...

By Dani Blum Dani Blum has reported on Covid since the spring of 2020 ... high-risk people before they get infected: a monoclonal antibody infusion called Pemgarda. And vaccines slash the risk ...

Yet antibody levels, the most easily measured form of immunity, do not seem to be notably contributing to our ability to blunt the latest forms of Covid. Vaccination rates around the world are ...

A new study has found that recipients of the BioNTech Covid-19 vaccine have 10 times more antibodies than those who took Sinovac, with the latter generating levels that are “similar or lower ...